The influenza A viruses continue to be major human pathogens (10, 30) . The mouse serves as a sensitive animal model for studying both pathogenesis and protective immunity (31) . Experimental infection of mice has been used to assess the sequence of organ involvement with respect to inoculum dose and local immune effector mechanisms. Infection with a high dose is initiated in the nose and descends into the trachea and lungs, resulting in cellular infiltration in the respiratory tract with interstitial pneumonia similar to that observed in severe human influenza (12) . In contrast, intranasal (i.n.) administration with a low dose restricts infection to the upper respiratory tract as in human disease (31) , yet abrogation of protective immunity in the nose leads to progressive infection of the trachea and lungs (26) .
Infection with influenza A viruses elicits a strong T-and B-cell response, which clears virus from the respiratory tract and protects against homologous challenge (5, 7) . Principal in the humoral immune response is the generation of antibodies to the hemagglutinin (HA) glycoprotein (reviewed in reference 45) . Evidence has progressively accumulated that the presence of anti-HA antibody in the lung compartment is an essential requirement for protection and recovery (17, (20) (21) (22) . Furthermore, Scherle et al. (38) showed that the intraperitoneal (i.p.) passive transfer of a cocktail of neutralizing anti-HA antibodies alone-including the immunoglobulin M (IgM), IgG, and IgA isotypes-into SCID mice 1 day postinfection led to virus clearance from the lungs and complete, long-term recovery. Also, Renegar and Small (32, 33) reported that intravenous passive transfer of HA-specific polymeric IgA led to specific transport into nasal secretions and protection against challenge.
The kinetics and localization patterns of the influenza virusspecific B-cell responses are less well understood. A complementary issue is how different antigenic forms of the HA that are presented to the immune system during infection or vaccination affect the primary antibody response and the development of B-cell memory. Hocart et al. (14) reported that late in the primary response to live virus inoculated i.p., the level and IgG subclass profile of virus-specific antibodies in lung washes differed significantly from those observed in serum, suggesting distinct antibody sources and kinetics in the systemic and lung compartments. Differential antibody localization, with a narrower IgG subclass profile, was also evident in the lungs and upper respiratory tract in response to either i.p. or i.n. vaccination with alternative HA forms such as purified HA (13, 14) . It is thought that protective antiviral IgG and IgA antibodies present in local secretions are not only derived from the serum (41) but also produced locally (17, 27, 41) . This finding strongly suggests an antibody-producing role for the lung compartment. Jones and Ada (20) provided the first evidence that the lungs themselves contain antibody-forming cells (AFCs) capable of generating antibody in response to pulmonary infection. The Ig isotype profile during the primary AFC response in the lung was dominated by IgM during the first 3 weeks, as was the case in the spleen. Use of various inoculation routes for both live and inactivated virus did not appreciably alter the finding of an overwhelming IgM response by primary AFCs in the lungs and spleen, as well as in vitro secondary responses (21, 22) . Recently, Fazekas et al. (10) provided preliminary evidence of an important role for lymph nodes draining the lungs during infection in the generation of virus-specific antibody.
In this study, we address the anatomic localization of influenza virus HA-specific AFCs within the lymph nodes that drain the upper and lower respiratory tracts and of the inflammatory cell population that can be recovered by bronchoalveolar lavage (BAL). The relative importance of B-cell localization to the lung compartment for memory AFC responsiveness to lethal challenge was examined in the context of alternative HA vaccines and CD4 ϩ T-cell help for B-cell immunity. The number and localization of HA-specific AFCs found during the anti-influenza virus response are primarily dependent on the antigen organization of the HA.
MATERIALS AND METHODS
Mice. Female BALB/c mice, obtained from the Jackson Laboratory (Bar Harbor, Maine), were maintained in specific-pathogen-free conditions until they were used at 8 to 10 weeks of age.
Virus and viral antigens. Virus stocks of egg-grown sucrose gradient-purified A/PR/8/34 (H1N1) or B/Ann Arbor/1/86 virus were prepared. In some experiments, a similarly purified preparation of Madin-Darby canine kidney (MDCK) cell-grown A/Memphis/7/90 (H3) ϫ PR8 (N1) reassortant virus (H3N1) (25) was also used as an immunogen.
The surface antigens, HA together with neuraminidase (NA), were extracted from influenza virus particles by the method of Johansson et al. (18) . The HA/NA-rich fraction was assessed for purity by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (8) , which indicated that under nonreducing conditions at room temperature, more than 98% of the proteins assumed representative oligomeric forms of HA and NA. Upon exposure to 100ЊC and reducing conditions, trimeric HA and quatromeric NA are dissociated to monomers. Density scans of monomeric profiles visualized by Coomassie blue staining were performed with a Sparc station 2 densitometer (Sun Systems, Mountain View, Calif.), using Bioimaging Visage 110 software (Millipore, Bedford, Mass.). The relative HA contents of virus and the HA/NA-rich fraction were estimated at 35 and 55%, respectively, and expressed as micrograms of HA (24) following protein concentration determination.
Formalin-inactivated virus was prepared and standardized as described by Katz and Webster (24) .
Antigen priming and challenge. Mice were infected i.n. under Avertin (2,2,2-tribromoethanol) anesthesia with 30 l of phosphate-buffered saline (PBS) containing virus doses ranging from 50 to 0.0025 g of HA. It should be noted that the micrograms-of-HA dosage designation is currently used for influenza virus vaccines and represents the antigenic mass of incoming virus but not necessarily its infectivity; this designation was used in favor of a consistent expression of the amount of HA delivered, regardless of the antigenic form of the vaccine. The same doses were given i.p. in 100 l in other mice. Alternatively, HA was presented in isolated HA/NA glycoprotein preparations at 50 g of HA in 100 l of PBS injected i.p. Mice were challenged i.n. with 5 g of HA (equivalent to 3 50% lethal doses) of live virus 24 to 32 days postimmunization. Some mice were inoculated i.n. with 0.025 g of normal allantoic fluid as a control.
Serological tests. Hemagglutination titration and hemagglutination inhibition (HI) tests were performed in microtiter plates with 0.5% chicken erythrocytes, with mouse sera treated with receptor-destroying enzyme (44) .
Tissue sampling. Mice were anesthesized and exsanguinated by heart puncture, and the following lymphoid tissues were collected on the stated days after immunization: representing the upper respiratory tract (mandibular and superficial cervical lymph nodes [CLN]), lower respiratory tract (mediastinal lymph node [MLN] and BAL), and the spleen and bone marrow (BM). Tissues were processed individually, with removal of erythrocytes and dead cells as previously described (1, 16) . Single-cell suspensions were prepared fresh from lymphoid tissues and sampled from individual mice (1) . Lungs that were taken for virus titration were not subjected to lavage. Leukocytes were resuspended in complete medium (Iscove's modified Dulbecco's medium or RPMI 1640 and 15% fetal calf serum) and used the same day. Tissues from two to three mice per group were analyzed individually.
Determination of lung virus titers. Lungs were processed as described previously (1, 26, 38) , and virus titers in lung extracts were expressed as the reciprocal of the highest dilution of the original homogenate that gave hemagglutination in 50% of replicate MDCK cell cultures. Negative samples were further tested by inoculation into the allantoic cavity of 10-day-old embryonated eggs, and allantoic fluid was assayed 3 days later for the presence of HA activity.
In vivo depletion of CD4 ؉ T cells. Helper T cells were depleted by i.p. injection with 0.5-ml aliquots of a CD4 ϩ T-cell-specific monoclonal antibody (GK1.5 ascites fluid) diluted in PBS (2 mg of protein per dose), given initially 3 days before antigen and repeated on day 0 and every 2 to 3 days afterward. This protocol was previously shown to eliminate the CD4 ϩ population (1). ELISPOT assays. Parameters of HA-specific B-cell responsiveness, in particular antibody secretion and Ig isotype profile determination, were determined by a modification of the enzyme-linked immunospot (ELISPOT) assay (6, 15, 16, 34, 39) . Briefly, to 96-well nitrocellulose plates (MultiScreen filtration plates; Millipore) was added 0.5 g of HA (in 100 l overnight at 4ЊC) of purified virus or HA/NA glycoprotein preparations from PR8, B/Ann Arbor, or MDCK cellgrown H3N1 reassortant virus; control titration plates were coated with normal allantoic fluid. Plates were washed three times with PBS and blocked with 2% fetal calf serum for 90 min prior to the addition of fivefold dilutions of lymphocytes. Incubation of a maximum of 10 6 cells per ml for 4 h at 37ЊC in a humid 5% CO 2 atmosphere was followed by several washes: once with PBS, once with PBS-0.1% Tween 20, and three times with PBS. HA-specific AFCs producing antibodies of the IgM, IgG, and IgA isotypes (IgM-, IgG-, and IgA-AFCs) were detected as spots following incubation with alkaline phosphatase-conjugated goat anti-mouse Ig isotype-specific reagents diluted in 5% bovine serum albumin, development with the peroxidase substrate 5-bromo-4-chloro-3-indolyl phosphate, and counting with an Olympus SZH Stereozoom microscope. The results shown are the means normalized to the number of AFCs per 10 5 cells; although there was some inherent variability in the number of AFCs between mice, similar results were obtained in the several time course experiments performed, and the findings shown are typically representative data.
RESULTS
The time course and Ig isotype profile of the humoral immune response to alternative HA forms in normal and CD4-depleted, naive and immune mice was examined at the singlecell level. Lymphoid tissues were assayed for total cell recovery and for estimation of the plasma cell response by determining the AFC frequency per 10 5 total cells. Increased cell recovery in lymphoid tissues following influenza virus infection. The patterns of cellular accumulation in the CLN, MLN, BM, and spleens of naive BALB/c mice infected i.n. with the PR8 (H1N1) virus, and of recovered PR8-primed mice that were later challenged with the same virus, were investigated, and the results are shown in Fig. 1 . The requirement for helper T cells was determined by using naive mice treated in vivo with monoclonal antibody GK1.5 to eliminate CD4 ϩ T cells prior to infection. Infection of mice with a range of doses of PR8 virus (equivalent to 50 and 0.0025 g of HA) is associated with a massive increase in the cellularity of the CLN by day 3 (six-to eightfold; Fig. 1a ), followed by peak counts in the MLN by day 7. The cell counts in the CLN and MLN increased enormously (less so in BAL) between days 2 and 3 (data not shown) but thereafter were recovered at a high level (Fig. 1 ). There were no significant changes in cellularity in the BM and spleen (data not shown). Cell numbers returned to background levels by day 14 in all tissues examined except the MLN, where cellular expansion was still evident. There was no effect on the cellularity of the spleen during the first 2 weeks (mean, 3 ϫ 10 7 cells per organ); however, a loss in splenic cell number and organ size is often seen in immune mice rechallenged i.n. with infectious virus (data not shown). In contrast, challenge brings on renewed cellular accumulation in the CLN and MLN (Fig. 1a and b) . Interestingly, only expansion in cell number in the MLN seems to be exclusively dependent on T-cell help provided by CD4 ϩ cells. The cellularity in the CLN and BAL was unaffected and was in fact comparable to levels in challenged immune mice. Thus, infection with live virus is a potent inducer of increased cellularity in both lymphoid tissues and the lung, the extent being dependent on antigen dose and T-cell help.
Primary HA-specific B-cell response to influenza virus is localized at the site of infection. In response to immunization with different doses of live PR8 virus (equivalent to 50 and 0.25 g of HA), frequencies of HA-specific IgM-AFCs in the respiratory tract were prominent in the CLN as early as day 3 to 4 and peaked by day 6 (Fig. 2a) . A larger population of HAspecific AFCs that switched to the IgG isotype emerged concurrently in mice given 50 g of HA (Fig. 2b ), but less so in response to the 200-fold-lower dose. A greater than 100-fold increase in the number of HA-specific IgG-AFCs was seen between days 4 and 6, representing about 0.1% of total cells in the CLN. The MLN demonstrated a similar Ig isotype distribution but showed slightly slower kinetics (data not shown). Few, if any, HA-specific AFCs were found in the CLN and MLN of naive, control mice (not shown). At a dose of 50 g of HA, there is generally a greater frequency (threefold more) of IgG-and IgA-AFCs in the MLN than in the CLN but fewer IgM producers. The AFC response in the BAL was essentially zero during the 32 days of study (not shown). Overall, the sum of the AFC frequencies in the CLN and MLN reached a peak of 0.6% of the total organ population by the end of the first week in response to infection with 50 g of HA of live virus (not shown).
The expansion in the number of AFCs in the CLN and MLN through the primary response is of brief duration, as the counts return to control levels within 1 week (Fig. 2a to c) , coincident with falling cell numbers in these tissues (Fig. 1) . The minority IgG-and IgA-AFCs in the CLN that persist help maintain the primary response at a low level (Fig. 2b and c) during the first 2 weeks following infection with a high dose but not with lower doses (Fig. 2d) . The presence of larger numbers of IgG-AFCs in the MLN on day 12 after primary infection (Fig. 2b) does not seem to be dose dependent (Fig. 2e) . The events in the regional lymph nodes do not require the maintenance of infectious virus, as there is no evidence of virus replication in the MLN (9) after virus is cleared from the lungs (day 12; not shown).
Analysis of the peripheral B-cell pool for AFCs generated during the primary response included examination of the spleen and BM (Fig. 3g to l) . Recent evidence has shown that maintenance of AFCs in the spleen and BM is an indicator of long-term antibody production (3, 28, 40, 41) , particularly in response to acute viral infection (16, 34) . Using an intermediate dose (0.0025 g of HA), AFCs were found at extremely low frequencies in the BM (Fig. 3g to i ) and the spleen (Fig. 3j to   l ) during the 32 days tested. No significant increase in AFCs was observed at a later time point (day 60; not shown). Yet, the B-cell response in the CLN (Fig. 3a to c) and MLN (Fig. 3d to  f) showed the expected kinetics and Ig isotype distribution. Overall, HA-specific AFCs induced by influenza virus infection are localized predominantly in the regional lymphoid tissues of the respiratory tract.
Localization in MLN of HA-specific memory AFC responsiveness to challenge. Inasmuch as the lung compartment is instrumental in the primary response to infection, memory B cells are disseminated throughout the host in secondary lymphoid tissues in readiness for challenge. We were interested in determining the relative importance of the lung compartment and other lymphoid tissues in response to lethal challenge. Mice were inoculated i.n. with 0.0025 g of HA of live PR8 and challenged i.n. with live virus (5 g of HA) after 32 days, and the AFC response was quantitated 3 days later (a time at which maximum cellularity is achieved; Fig. 1a and b) . The interval between immunization and challenge was chosen since AFCs were no longer detected by day 32 (Fig. 3) . The memory B-cell pool expanded exponentially within 3 days of challenge to generate AFCs: expansion in AFC numbers was seen principally in the MLN (Fig. 3e and f) , with a minor component in the CLN (Fig. 3b and c) . Meanwhile, lung virus titers on day 3 were as follows: Ͻ10 1 for mice primed with 0.0025 g of HA live virus and challenged with 5 g of HA of same, in contrast to 10 2.5 for mice primed with 50 g of HA of live PR8. Very low or undetectable frequencies were present in the BM (Fig.  3g to i) , spleen (Fig. 3j to l) , and BAL (not shown). Total AFC numbers outside the respiratory tract lymphoid tissues represent less than 10% of those in the CLN and MLN. Highermemory AFC responsiveness was seen in the group primed with 0.0025 g of HA of live virus rather than with a higher dose (50 g of HA), even with a challenge of 50 g of HA of live virus (data not shown).
The extent of the clonal expansion in the MLN following challenge is remarkable, reaching almost 300 IgG-AFCs per 10 5 total cells on day 3 (Fig. 3e) . This amounts to a fourfold increase over the maximum day 12 primary response. Assuming a B-cell cellularity of 50% of the total (36), more than 4 ϫ 
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4 IgG-AFCs were located in this tissue within 3 days of challenge. This number of AFCs is associated with a serum HI titer of about 1:10 2 on day 3, having increased from undetectable levels 7 days after priming with 0.0025 g of HA of live virus. Within 1 week of challenge, serum HI titers reached peak levels of 1:10 3 . All immunized mice survived challenge by the end of the second week, and no lung virus was detected (not shown). The absence of any IgM-AFCs in the MLN (Fig. 3d) and CLN (Fig. 3a) further indicates that the response to challenge was secondary. In addition to the marked IgG-AFC response in the MLN, a substantial proportion (40%) of HA-specific B cells had switched to the IgA isotype (Fig. 3f) . In naive mice, 14 days were needed for the number of IgG-AFCs in the MLN to increase to 43/10 5 (not shown), and the response clearly showed primary kinetics. The divergence between the MLN and CLN seen in the primary response with regard to kinetics ( Fig. 3a and d) is less apparent in the more rapid secondary response. The capacity to respond quickly to i.n. challenge is localized to the MLN, which could reflect the supply of memory B cells in this tissue or the localization of antigen (or Ig-virus complexes) via afferent lymph.
T-cell help dependence of HA-specific B-cell responses to live virus. Influenza virus is known to induce in T-cell-deficient mice an exclusively IgM antiviral antibody response, which is ineffective in clearing virus (5) . The source of these antibodies as well as the kinetics of their production were investigated in anti-CD4-treated mice. Helper T-cell-deficient mice were immunized with live virus (50 g of HA), and ELISPOT analysis was done on days 3 and 7 thereafter. Live virus induced remarkable levels of IgM-AFCs that were localized predominantly in the CLN (Fig. 4a) , coincident with the increased cellularity of this organ (Fig. 1a) . The extent of the peak response on day 3 was more than 6 ϫ 10 2 AFCs per 10 5 total cells, four times greater than in normal mice. In contrast, the spleen and MLN in CD4-depleted mice contained only minor IgM-AFC populations ( Fig. 4a and d) . Even with the high dose of live virus, giving rise to a lung virus titer of Ͼ10 3 on day 3, no measurable IgG (Fig. 4b and e) or IgA ( Fig. 4c and f) group was associated with a low level of protection (20%, 2 of 10 with lung virus titers of Ͻ10 3 ), which was three times less than that in normal mice. In response to live virus given i.p., IgM-AFCs were localized entirely in the spleen (not shown). Therefore, HA presented on the surface of a live virus does not require T-cell help to elicit IgM-AFCs, but the response is restricted to the priming site.
Limited HA-specific B-cell responses to alternative forms of HA. The influence of antigen organization of the HA on the B-cell response was examined in normal and CD4-depleted mice injected i.p. with inactivated or subunit vaccine (50 g of HA). The effect of antigen disorganization, by extraction of the HA from the virus surface, on B-cell responsiveness was determined on days 3, 7, and 14. Normal mice primed with subunit vaccine showed elevated numbers of AFCs (more than 6 ϫ 10 2 /10 5 total cells at peak on day 7) but only in the spleen and with threefold more IgM-AFCs than IgG producers ( Fig.  4g and h ). Serum HI titers reached maximum (1:10 2 ) within 2 weeks of immunization. In contrast, inactivated vaccine (in which HA organization remains unchanged) given i.p. induced greater numbers of IgG-than IgA-AFCs (data not shown) within 2 weeks, similar to the level produced by replicating virus when given by the same route. Priming of CD4-depleted mice with HA glycoprotein failed to generate IgM-AFCs as well as IgG-producing cells in all tissues tested (CLN, MLN, and BM; results for spleen shown in Fig. 4g and h) . Live virus challenge (5 g of HA) 24 days later showed little B-cell responsiveness on day 3 (Fig. 4i to l) or later, in weeks 1 and 2 (not shown). This finding is in contrast to the secondary albeit limited AFC responsiveness in the spleen in normal immune mice, which peaked on day 3 ( Fig. 4k and l) ; serum HI titers did not increase appreciably above 1:10 2 within the 2 weeks of study. A greater than fivefold difference in the level of protection against challenge (5 g of HA of live virus) was seen between normal and CD4-depleted mice on day 3 (fewer than 10% [1 of 12] of CD4-depleted mice showed lung virus titers of Ͻ10 3 , whereas 5 of 10 CD4 ϩ mice had virus titers of Ͼ10
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). These results indicate that HA does not possess an intrinsic ability to induce a helper T-cell-independent IgM effector or memory B-cell response. Instead, HA needs to be presented in a highly organized form and requires T-cell help for the switch to IgG or IgA.
HA specificity of AFC responsiveness is related to antigen form. Inasmuch as the HA presented on the virus surface is immunodominant over the NA (19), we were interested in determining the influence of N1 in the B-cell response. Naive mice were primed with live virus or a subunit vaccine preparation from PR8, the H3N1 reassortant, or a type B virus. Comparative AFC specificity was determined on plates coated with H1N1 and H3N1 glycoproteins, the latter of which was derived from MDCK cell-derived virus. The H3N1 virus is a reassortant which differs from PR8 solely by its HA: differential assay on egg-and cell-derived HA is a convenient measure of nonspecific cross-reactivity. To further discount any influence of chicken embryo-derived carbohydrate moieties associated with HA and NA, primary and memory AFCs were assayed on plates coated with normal allantoic fluid ( Fig. 5a and  b) . The results show that H1N1-induced AFCs secreting IgM or IgG either were not detected (CLN and MLN) or were found at extremely low frequencies in the BM and spleen. Similarly, assay of lymphoid tissues (CLN, MLN, BM, and spleen) from naive mice primed i.n. with normal allantoic fluid (0.025 g of protein per mouse) on plates coated with H1N1 and H3N1 glycoproteins failed to detect any AFCs (not shown).
The specificity of primary AFCs from infected mice was predominantly restricted to the homologous HA. The partial recognition of heterologous HA was localized to IgM producers in the CLN (Fig. 5c ) but not to IgG-AFCs (Fig. 5d) or IgA-AFCs (not shown). In contrast, mice primed with subunit vaccine generated an additional splenic AFC population specific for the NA, revealing an IgM-to-IgG ratio of about 3.5 ( Fig. 5c and d) , similar to that observed for HA. Approximately two-thirds of IgM-and IgG-AFCs were directed to the N1 antigen; equivalent results were observed with detergent-disrupted whole virus as the coating antigen (not shown). Specificity for NA is possible because dissociation of the influenza virus glycoproteins from the virus surface eliminates their intravirionic antigenic competition (19) , resulting in an equivalent capacity to generate antibody responses (18) . Both HAand NA-specific AFCs elicited by subunit vaccine were eliminated in CD4-depleted mice (not shown), thus demonstrating their dependence on T-cell help. Nevertheless, the predominant AFC specificity is directed to HA, the extent of which is dependent on the antigen organization of the HA. 
DISCUSSION
In this report, we demonstrate that primary B-cell and memory AFC responsiveness to pulmonary influenza virus infection is primarily localized in the lymphoid tissues of the upper and lower respiratory tracts and is markedly influenced by the antigen organization of viral HA. Using single-cell ELISPOT analysis, we can directly monitor the Ig isotype profile of HAspecific AFCs, their localization and frequency within lymphoid tissues, and the kinetics of the antibody response as it relates to the antigenic forms of HA available during the evolution of disease. Specifically, immunization of hitherto naive mice by infection with a very low dose effectively promoted recovery from lethal challenge, by primarily restricting the memory AFC response to those lymph nodes (but not the BAL) draining the site of antigen localization in the respiratory tract (CLN and MLN) . In the absence of help provided by CD4 ϩ T cells, AFC localization was further restricted to the upper respiratory tract (CLN) but did not generate the isotype switch from IgM to IgG or IgA necessary for recovery and was not protective against challenge. In the absence of antigenic organization of HA on the virion surface, in the context of an oligomeric glycoprotein complex with NA, HA predominantly induced IgM-AFC and did not effectively seed memory B cells in the lung compartment (or elsewhere, in the spleen and BM). The application of this approach to analyzing humoral immunity has revealed the importance of the lymphoid tissues of the lung compartment in the establishment of immunological memory that is HA specific, capable of memory AFC responsiveness at the site of challenge.
What determines AFC responsiveness to influenza virus HA in the lung compartment? A reasonable explanation is the enhanced cellular infiltration in the responding CLN and MLN, and presumably the lung tissue itself, although the cellularity of the BAL is unaffected and is absent of detectable B lymphocytes (1) . The BAL and grossly swollen lymph nodes provide and reflect the cytokine-rich milieu (4, 35, 36) necessary for efficient T-cell help and B-cell differentiation into AFCs and memory cells in the MLN and CLN. Influenza virus replicates in the mouse lung following i.n. exposure, with there being little evidence of persistence of any viral genomic material in the lungs, regional MLN, or spleen, even in CD4-depleted mice (9) . In contrast to the lung and BAL, it is the microenvironment of the MLN that determines immune responsiveness (36) . Maintenance of antibody levels is likely due to the persistence of viral antigen on the surface of follicular dendritic cells in lymphoid tissue (42) , which is thought to be sufficient to retain memory AFCs in the BM (16, 34, 40) . Cognate interaction between virus-specific helper T cells and HA-specific B cells is an essential requirement for generating a complete isotype (IgM, IgG, and IgA) composition in the response to infection (37) . In contrast, limitation of the HAspecific AFC response occurs in the absence of T-cell help, which does not change with secondary challenge. Whether the diverse specificity of CD4 ϩ T-cell help or the differential cytokine secretion profile of helper T-cell subsets can account for the Ig isotype profile of AFCs in the lungs, and elsewhere, under our experimental conditions is still unclear.
The role of the lungs in generating AFCs is not completely understood. In the murine influenza virus model, early evidence suggested that pulmonary infection in mice leads to the detection of AFCs in the lungs. Jones and Ada (20, 21) have shown that IgM-producing cells are first detected in the spleen and then the lungs, followed by IgG-and IgA-AFCs in the lungs in 3 weeks. Furthermore, these investigators have shown that prolonged in vitro restimulation of lung cells is generally required before AFCs are detected. In their hands, immunization with influenza virus vaccines by various inoculation routes results in equivalent Ig isotype profiles and AFC kinetics in the spleen and lungs. On the other hand, we report that IgM-AFCs appear first in CLN draining the upper respiratory tract and shortly thereafter in the MLN, with peak IgG-and IgA-AFC numbers within 1 to 2 weeks, but little or none are detected in the BAL. The significance of the CLN response is strengthened by the observation that in the absence of CD4 ϩ T-cell help, only this tissue responds to infection. However, the spleen responds mainly to HA when inoculated i.p. Nevertheless, the MLN dominates the response to challenge, but this does not preclude the possibility that lung tissue contains AFCs, derived from regional lymph nodes, the spleen, or bronchus-associated lymphoid tissue (29) . A recent report is in support of this view (10) . The reason(s) for the differences between our study and those of Jones and Ada is not clear, but possibilities include our sampling of freshly isolated lymphoid tissues, the use of a consistent single-cell assay that allows identification of the complete Ig isotype composition of the response (15, 16, 34) , and the strict enumeration of HA-specific AFCs. Primary infection in BALB/c mice does generate antibodies to the matrix and nucleoprotein internal proteins (37) , but more than 50% are directed to HA, and only anti-HA antibodies are neutralizing (5, 45) . The extent and influence of lymphoid infiltrates that produce and retain AFCs in the lungs remain to be determined.
The mechanisms by which antigen delivery determines memory AFC responsiveness are now more fully understood. Bachmann et al. (3) have shown that memory B cells are induced at the priming site and recirculate throughout the lymphoid system independently of antigen localization and the form of the antigen used for inoculation. Memory AFCs are generated only where challenge antigen is present, which may be distant from the priming site. Our findings here and elsewhere (23, 25) fit this recently presented model, but there are caveats. We find that different HA forms that vary on the basis of antigen organization provide dissimilar levels of immunity, partly because challenge does not necessarily generate HA-specific memory AFCs in the lymph nodes draining the lung. HA presented by live virus i.n. infection and by gene gun inoculation of DNA-encoded vaccine into the skin provides the most efficient means of generating protective memory B cells in the lung compartment. Instead, memory AFCs elicited by subunit vaccine are restricted to the IgM isotype and to the spleen, close to the priming site. These findings support the conclusion that antigen organization influences B-cell immunity (2) .
The finding of disparate memory AFC localization in response to challenge in the different vaccine groups has obvious implications for development of vaccines for humans. Unlike live vaccines, parenteral vaccines possess a protective ceiling due in part to their relative inability to elicit mucosal immunity (43) . New strategies which enhance the mucosal immunity engendered by conventional vaccines have been developed. Experiments are currently under way to investigate whether mucosal vaccines can be optimized to generate protective memory IgG-and IgA-AFCs against disease.
